KRAS and neoplasm: Moreover, primary tumor cells exhibit upregulation of the MYC signaling pathway and response to alpha and beta interferon signaling pathways, distinguishing them to some extent from metastatic tumor cells that predominantly utilize the KRAS signaling pathway, which reveals the distinct pathway adopting by primary and metastatic tumor cells (Fig. 4A and B).